Acacia Research Corporation ACTG announced today that a
subsidiary has acquired 7 patent portfolios with over 1,900 patents and
applications relating to stent grafts, vascular grafts, bypass grafts,
graft retrieval technology, graft manufacturing technology, vena cava
filter technology, and filter retrieval technology from a leading global
medical device company.
“As Acacia's licensing success in the medical technology sector grows,
we are pleased to announce that a leading global medical device company
has chosen Acacia as their trusted partner for the licensing of their
patented technologies,” commented Paul Ryan, Acacia CEO.
“This transaction is one of our largest partnerships to date and is a
validation of our
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in